| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
9,722 |
8,463 |
$734K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,305 |
8,508 |
$621K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,836 |
4,527 |
$342K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,737 |
1,452 |
$225K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,894 |
2,141 |
$162K |
| 80053 |
Comprehensive metabolic panel |
6,219 |
4,877 |
$152K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,419 |
1,934 |
$104K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,297 |
1,178 |
$99K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,865 |
3,469 |
$99K |
| 36415 |
Collection of venous blood by venipuncture |
12,272 |
8,367 |
$53K |
| G0378 |
Hospital observation service, per hour |
3,913 |
1,531 |
$35K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
947 |
795 |
$30K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,327 |
2,559 |
$25K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,474 |
1,949 |
$24K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
111 |
97 |
$21K |
| 90791 |
Psychiatric diagnostic evaluation |
2,111 |
1,734 |
$20K |
| 81025 |
|
2,265 |
1,980 |
$20K |
| 87631 |
|
718 |
662 |
$19K |
| 80047 |
|
1,780 |
1,425 |
$10K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,590 |
1,406 |
$8K |
| 82948 |
|
3,065 |
969 |
$8K |
| 81003 |
|
6,448 |
5,310 |
$8K |
| 84484 |
|
4,115 |
2,270 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
921 |
799 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,126 |
10,111 |
$6K |
| 71045 |
Radiologic examination, chest; single view |
3,883 |
3,016 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,140 |
684 |
$6K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,049 |
778 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
922 |
850 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,640 |
1,339 |
$4K |
| A9270 |
Non-covered item or service |
1,183 |
447 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,031 |
2,252 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,892 |
3,720 |
$3K |
| 73562 |
|
138 |
113 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
745 |
675 |
$2K |
| 83880 |
|
1,589 |
1,172 |
$1K |
| 84703 |
|
1,317 |
1,140 |
$1K |
| 82330 |
|
1,572 |
1,296 |
$1K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
457 |
398 |
$1K |
| 87040 |
|
683 |
546 |
$1K |
| 83690 |
|
2,538 |
2,059 |
$1K |
| 85610 |
|
1,282 |
943 |
$996.51 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
742 |
674 |
$948.38 |
| 73610 |
|
40 |
37 |
$846.24 |
| 72100 |
|
93 |
65 |
$801.70 |
| 81001 |
|
322 |
274 |
$715.10 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
199 |
155 |
$676.21 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
55 |
54 |
$665.66 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
288 |
242 |
$600.44 |
| 87510 |
|
591 |
532 |
$581.08 |
| 87660 |
|
591 |
532 |
$574.06 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
83 |
66 |
$570.63 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
401 |
266 |
$546.60 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
29 |
26 |
$534.69 |
| 87641 |
|
82 |
72 |
$481.90 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
109 |
83 |
$481.55 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
50 |
37 |
$481.55 |
| 84145 |
|
195 |
151 |
$453.38 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
24 |
19 |
$419.71 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,016 |
721 |
$347.91 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,052 |
1,569 |
$294.35 |
| 73030 |
|
30 |
25 |
$265.02 |
| 80076 |
|
126 |
110 |
$259.74 |
| 87480 |
|
594 |
537 |
$199.75 |
| 85730 |
|
78 |
65 |
$186.86 |
| 85027 |
|
743 |
521 |
$157.62 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
387 |
299 |
$156.65 |
| 0353U |
|
37 |
32 |
$150.54 |
| 80061 |
Lipid panel |
85 |
72 |
$146.74 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
13 |
12 |
$145.25 |
| 83735 |
|
733 |
516 |
$95.73 |
| 76830 |
Ultrasound, transvaginal |
27 |
24 |
$71.05 |
| 87077 |
|
356 |
280 |
$68.79 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
827 |
604 |
$54.83 |
| 73630 |
|
14 |
12 |
$35.85 |
| 87640 |
|
29 |
27 |
$8.34 |
| J1630 |
Injection, haloperidol, up to 5 mg |
23 |
12 |
$1.43 |
| J2060 |
Injection, lorazepam, 2 mg |
478 |
331 |
$0.71 |
| 0352U |
|
17 |
15 |
$0.00 |
| 83605 |
|
589 |
448 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
179 |
148 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
219 |
133 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
16 |
12 |
$0.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
26 |
24 |
$0.00 |
| 85652 |
|
13 |
12 |
$0.00 |
| 86901 |
|
14 |
12 |
$0.00 |
| 82077 |
|
13 |
13 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
51 |
38 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
33 |
24 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
47 |
39 |
$0.00 |
| 86140 |
|
37 |
29 |
$0.00 |
| 82550 |
|
17 |
14 |
$0.00 |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
13 |
12 |
$0.00 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
13 |
12 |
$0.00 |
| 87186 |
|
242 |
191 |
$0.00 |
| 84702 |
|
45 |
37 |
$0.00 |
| 86900 |
|
14 |
12 |
$0.00 |
| 80164 |
|
23 |
14 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
26 |
12 |
$0.00 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
23 |
13 |
$0.00 |